METASTATIC PROSTATE ADENOCARCINOMA
Clinical trials for METASTATIC PROSTATE ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PROSTATE ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC PROSTATE ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Fighting fire with fire: High-Testosterone therapy aims to shock resistant prostate cancer
Disease control Recruiting nowThis study is testing if giving very high doses of testosterone, along with chemotherapy or a targeted radiation drug, can help control advanced prostate cancer that has spread and stopped responding to standard hormone-lowering treatments. The idea is to shock cancer cells that …
Matched conditions: METASTATIC PROSTATE ADENOCARCINOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for Tough-to-Treat prostate cancer
Disease control Recruiting nowThis study is testing if adding a drug called vorinostat makes a newer radioactive cancer treatment work better for men with advanced prostate cancer. The cancer has spread and stopped responding to standard hormone treatments. Researchers want to see if vorinostat can 'turn on' …
Matched conditions: METASTATIC PROSTATE ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Major trial aims to extend lives for men with spreading prostate cancer
Disease control Recruiting nowThis large study is testing if adding a chemotherapy drug (docetaxel) to the current standard two-drug hormone therapy helps men with prostate cancer that has spread live longer. It will enroll about 1,260 men to compare the three-drug combination against the standard two-drug tr…
Matched conditions: METASTATIC PROSTATE ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New hope for tough prostate cancer: Two-Drug attack begins human testing
Disease control Recruiting nowThis early-stage study is testing whether adding the drug ruxolitinib to the standard treatment enzalutamide is safe and effective for men with advanced prostate cancer that has stopped responding to hormone-blocking therapy. The goal is to find the best dose and see if this comb…
Matched conditions: METASTATIC PROSTATE ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New immune cell therapy targets advanced prostate cancer that has stopped responding to standard treatments
Disease control Recruiting nowThis trial tests whether a new type of cell therapy (STEAP1 CART) combined with the hormone drug enzalutamide can help control advanced prostate cancer that has spread and stopped responding to standard treatments. The study will enroll 48 men whose cancer has progressed despite …
Matched conditions: METASTATIC PROSTATE ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Shocking approach: giving testosterone to fight prostate cancer
Disease control Recruiting nowThis study tests a combination treatment for men with advanced prostate cancer that has spread to bones and stopped responding to standard hormone therapy. Participants receive monthly testosterone injections along with a targeted radiation drug that goes to bone areas. The goal …
Matched conditions: METASTATIC PROSTATE ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
Scientists test Two-Drug punch for tough prostate cancer
Disease control Recruiting nowThis study is testing a two-step treatment for advanced prostate cancer that has spread and stopped responding to standard hormone therapies and chemotherapy. First, patients take a pill (abemaciclib) for two weeks, aiming to make cancer cells more visible. Then, they receive a t…
Matched conditions: METASTATIC PROSTATE ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Vadim S Koshkin • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
New combo attack on advanced prostate cancer
Disease control Recruiting nowThis study is testing whether adding a new targeted drug called talazoparib to standard hormone-blocking treatments can better control advanced prostate cancer that has spread. It aims to see if this combination helps stop cancer growth for longer by preventing cancer cells from …
Matched conditions: METASTATIC PROSTATE ADENOCARCINOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 10, 2026 12:52 UTC